A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy (IMPROVE - Lap Colectomy)

Trial Profile

A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy (IMPROVE - Lap Colectomy)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2014

At a glance

  • Drugs Bupivacaine (Primary) ; Ketorolac; Morphine; Nonsteroidal anti-inflammatories
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IMPROVE-Lap Colectomy
  • Sponsors Pacira Pharmaceuticals
  • Most Recent Events

    • 15 Apr 2014 Trial status changed from completed to discontinued as reported by ClinicalTrials.gov record (NCT02058290).
    • 15 Apr 2014 Trial status changed from completed to discontinued as reported by ClinicalTrials.gov record (NCT02058290).
    • 15 Apr 2014 Trial status changed from completed to discontinued as reported by ClinicalTrials.gov record (NCT02058290).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top